Gregory M. Chen

2.9k total citations
10 papers, 667 citations indexed

About

Gregory M. Chen is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Gregory M. Chen has authored 10 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Pharmacology. Recurrent topics in Gregory M. Chen's work include CAR-T cell therapy research (4 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers) and Marine Sponges and Natural Products (2 papers). Gregory M. Chen is often cited by papers focused on CAR-T cell therapy research (4 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers) and Marine Sponges and Natural Products (2 papers). Gregory M. Chen collaborates with scholars based in United States, Canada and Germany. Gregory M. Chen's co-authors include Deena M.A. Gendoo, Benjamin Haibe‐Kains, Nathan A. Magarvey, Michael A. Skinnider, Chris A. Dejong, Chad W. Johnston, Kai Tan, Diane Provencher, Kurosh Rahimi and Cécile Le Page and has published in prestigious journals such as Cancer Research, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Gregory M. Chen

10 papers receiving 661 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory M. Chen United States 8 295 288 163 126 112 10 667
Xiuyan Yu China 16 412 1.4× 277 1.0× 264 1.6× 29 0.2× 23 0.2× 35 916
Erin Sult United States 8 255 0.9× 374 1.3× 288 1.8× 14 0.1× 348 3.1× 10 797
Coral Ampurdanés Spain 14 480 1.6× 534 1.9× 191 1.2× 15 0.1× 37 0.3× 19 888
Zhen Tong United Kingdom 8 453 1.5× 206 0.7× 46 0.3× 36 0.3× 14 0.1× 10 714
Sarah Lévesque France 12 251 0.9× 186 0.6× 170 1.0× 17 0.1× 25 0.2× 14 605
Yana Li United States 11 337 1.1× 120 0.4× 246 1.5× 28 0.2× 10 0.1× 20 640
Shih‐Chieh Chiang United Kingdom 13 509 1.7× 333 1.2× 203 1.2× 67 0.5× 6 0.1× 15 837
Biswanath Majumder India 18 528 1.8× 287 1.0× 254 1.6× 35 0.3× 8 0.1× 38 1.1k
Kristina Iribarren France 15 387 1.3× 382 1.3× 667 4.1× 20 0.2× 35 0.3× 18 1.1k
Ji Hye Shin South Korea 13 523 1.8× 152 0.5× 75 0.5× 22 0.2× 15 0.1× 28 766

Countries citing papers authored by Gregory M. Chen

Since Specialization
Citations

This map shows the geographic impact of Gregory M. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory M. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory M. Chen more than expected).

Fields of papers citing papers by Gregory M. Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory M. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory M. Chen. The network helps show where Gregory M. Chen may publish in the future.

Co-authorship network of co-authors of Gregory M. Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory M. Chen. A scholar is included among the top collaborators of Gregory M. Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory M. Chen. Gregory M. Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Chen, Gregory M., et al.. (2022). Characterization of Leukemic Resistance to CD19-Targeted CAR T-cell Therapy through Deep Genomic Sequencing. Cancer Immunology Research. 11(1). 13–19. 2 indexed citations
2.
Chen, Gregory M., J. Joseph Melenhorst, & Kai Tan. (2022). B cell targeting in CAR T cell therapy: Side effect or driver of CAR T cell function?. Science Translational Medicine. 14(650). eabn3353–eabn3353. 13 indexed citations
3.
Chen, Gregory M., Changya Chen, Rajat K. Das, et al.. (2021). Integrative Bulk and Single-Cell Profiling of Premanufacture T-cell Populations Reveals Factors Mediating Long-Term Persistence of CAR T-cell Therapy. Cancer Discovery. 11(9). 2186–2199. 124 indexed citations
4.
Chen, Gregory M., et al.. (2020). Dissecting the Tumor–Immune Landscape in Chimeric Antigen Receptor T-cell Therapy: Key Challenges and Opportunities for a Systems Immunology Approach. Clinical Cancer Research. 26(14). 3505–3513. 22 indexed citations
5.
Gendoo, Deena M.A., Vandana Sandhu, Venkata Manem, et al.. (2019). MetaGxData: Clinically Annotated Breast, Ovarian and Pancreatic Cancer Datasets and their Use in Generating a Multi-Cancer Gene Signature. Scientific Reports. 9(1). 8770–8770. 28 indexed citations
6.
Chen, Gregory M., Sarshan R. Pather, & Horace M. DeLisser. (2019). Trends in the Use of Common Words and Patient-Centric Language in the Titles of Medical Journals, 1976-2015. JAMA Network Open. 2(3). e191083–e191083. 6 indexed citations
7.
Chen, Gregory M., Lavanya Kannan, Ludwig Geistlinger, et al.. (2018). Consensus on Molecular Subtypes of High-Grade Serous Ovarian Carcinoma. Clinical Cancer Research. 24(20). 5037–5047. 84 indexed citations
8.
Johnston, Chad W., Michael A. Skinnider, Chris A. Dejong, et al.. (2016). Assembly and clustering of natural antibiotics guides target identification. Nature Chemical Biology. 12(4). 233–239. 87 indexed citations
9.
Dejong, Chris A., Gregory M. Chen, Haoxin Li, et al.. (2016). Polyketide and nonribosomal peptide retro-biosynthesis and global gene cluster matching. Nature Chemical Biology. 12(12). 1007–1014. 94 indexed citations
10.
Turcotte, Martin, Kathleen Spring, Sandra Pommey, et al.. (2015). CD73 Is Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer. Cancer Research. 75(21). 4494–4503. 207 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026